- edoc Startseite
- Auflistung nach Autor
Auflistung nach Autor "Kaufmann, Andreas M."
Anzeige der Publikationen 1-4 von 4
-
2017-09-04ZeitschriftenartikelCost-effectiveness of human papillomavirus vaccination in Germany Damm, Oliver; Horn, Johannes; Mikolajczyk, Rafael T.; Kretzschmar, Mirjam E. E.; Kaufmann, Andreas M.; Deleré, Yvonne; Ultsch, Bernhard; Wichmann, Ole; Krämer, Alexander; Greiner, WolfgangBackground: The aim of this study was to assess the cost-effectiveness of human papillomavirus (HPV) vaccination in addition to the current cervical cancer screening programme in Germany using a dynamic transmission ...
-
2014-10-11ZeitschriftenartikelFeasibility and acceptance of cervicovaginal self-sampling within the German National Cohort (Pretest 2) Castell, Stefanie; Krause, Gérard; Schmitt, M.; Pawlita, M.; Deleré, Yvonne; Obi, N.; Flesch-Janys, D.; Kemmling, Y.; Kaufmann, Andreas M.Hintergrund und Ziele: In der Nationalen Kohorte (NAKO) werden 100.000 erwachsene Frauen in Deutschland umfassend befragt und untersucht werden. Während Frauengesundheit im Basisinterview thematisiert wird, ist der ...
-
2014-02-19ZeitschriftenartikelHuman Papillomavirus prevalence and probable first effects of vaccination in 20 to 25 year-old women in Germany: a population-based cross-sectional study via home-based self-sampling Deleré, Yvonne; Remschmidt, Cornelius; Leuschner, Josefine; Schuster, Melanie; Fesenfeld, Michaela; Schneider, Achim; Wichmann, Ole; Kaufmann, Andreas M.Background: Estimates of Human Papillomavirus (HPV) prevalence in a population prior to and after HPV vaccine introduction are essential to evaluate the short-term impact of vaccination. Methods: Between 2010 and ...
-
2014-12-05ZeitschriftenartikelSexual behavior and factors associated with young age at first intercourse and HPV vaccine uptake among young women in Germany: implications for HPV vaccination policies Remschmidt, Cornelius; Fesenfeld, Michaela; Kaufmann, Andreas M.; Deleré, YvonneBackground: In Germany, immunization against human papillomaviruses (HPV) is free of charge for all females aged 12 to 17 years. Since HPV infection rates rise soon after first intercourse, immunization against HPV ...